Current management of the infant who presents with neonatal encephalopathy
- PMID: 21458747
- DOI: 10.1016/j.cppeds.2010.12.002
Current management of the infant who presents with neonatal encephalopathy
Abstract
Neonatal encephalopathy after perinatal hypoxic-ischemic insult is a major contributor to global child mortality and morbidity. Brain injury in term infants in response to hypoxic-ischemic insult is a complex process evolving over hours to days, which provides a unique window of opportunity for neuroprotective treatment interventions. Advances in neuroimaging, brain monitoring techniques, and tissue biomarkers have improved the ability to diagnose, monitor, and care for newborn infants with neonatal encephalopathy as well as predict their outcome. However, challenges remain in early identification of infants at risk for neonatal encephalopathy, determination of timing and extent of hypoxic-ischemic brain injury, as well as optimal management and treatment duration. Therapeutic hypothermia is the most promising neuroprotective intervention to date for infants with moderate to severe neonatal encephalopathy after perinatal asphyxia and has currently been incorporated in many neonatal intensive care units in developed countries. However, only 1 in 6 babies with encephalopathy will benefit from hypothermia therapy; many infants still develop significant adverse outcomes. To enhance the outcome, specific diagnostic predictors are needed to identify patients likely to benefit from hypothermia treatment. Studies are needed to determine the efficacy of combined therapeutic strategies with hypothermia therapy to achieve maximal neuroprotective effect. This review focuses on important concepts in the pathophysiology, diagnosis, and management of infants with neonatal encephalopathy due to perinatal asphyxia, including an overview of recently introduced novel therapies.
© 2011 Published by Mosby, Inc.
Comment in
-
Foreword. Neonatal encephalopathy.Curr Probl Pediatr Adolesc Health Care. 2011 May-Jun;41(5):131. doi: 10.1016/j.cppeds.2010.12.001. Curr Probl Pediatr Adolesc Health Care. 2011. PMID: 21458746 No abstract available.
Similar articles
-
New pharmacological approaches in infants with hypoxic-ischemic encephalopathy.Curr Pharm Des. 2012;18(21):3086-100. Curr Pharm Des. 2012. PMID: 22564301
-
Intervention strategies for neonatal hypoxic-ischemic cerebral injury.Clin Ther. 2006 Sep;28(9):1353-65. doi: 10.1016/j.clinthera.2006.09.005. Clin Ther. 2006. PMID: 17062309 Review.
-
State of the science: hypoxic ischemic encephalopathy and hypothermic intervention for neonates.Adv Neonatal Care. 2010 Apr;10(2):60-6; quiz 67-8. doi: 10.1097/ANC.0b013e3181d54b30. Adv Neonatal Care. 2010. PMID: 20386369 Review.
-
Hypoxic ischemic encephalopathy and hypothermia: a critical look.Obstet Gynecol. 2005 Dec;106(6):1385-7. doi: 10.1097/01.AOG.0000190206.70375.b4. Obstet Gynecol. 2005. PMID: 16319267 Review.
-
Therapeutic hypothermia for newborn infants with hypoxic-ischaemic encephalopathy.J Paediatr Child Health. 2010 Oct;46(10):568-76. doi: 10.1111/j.1440-1754.2010.01880.x. Epub 2010 Sep 16. J Paediatr Child Health. 2010. PMID: 20846275 Review.
Cited by
-
Desflurane Post-treatment Reduces Hypoxic-ischemic Brain Injury via Reducing Transient Receptor Potential Ankyrin 1 in Neonatal Rats.Neuroscience. 2023 Jul 1;522:121-131. doi: 10.1016/j.neuroscience.2023.05.007. Epub 2023 May 15. Neuroscience. 2023. PMID: 37196978 Free PMC article.
-
Clinical Implications of Epigenetic Dysregulation in Perinatal Hypoxic-Ischemic Brain Damage.Front Neurol. 2020 Jun 9;11:483. doi: 10.3389/fneur.2020.00483. eCollection 2020. Front Neurol. 2020. PMID: 32582011 Free PMC article. Review.
-
TrkB receptor agonist 7, 8 dihydroxyflavone triggers profound gender- dependent neuroprotection in mice after perinatal hypoxia and ischemia.CNS Neurol Disord Drug Targets. 2013 May 1;12(3):360-70. doi: 10.2174/18715273113129990061. CNS Neurol Disord Drug Targets. 2013. PMID: 23469848 Free PMC article.
-
GW0742 activates miR-17-5p and inhibits TXNIP/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells.J Cell Mol Med. 2020 Nov;24(21):12318-12330. doi: 10.1111/jcmm.15698. Epub 2020 Oct 9. J Cell Mol Med. 2020. PMID: 33034416 Free PMC article.
-
Serum neuron-specific enolase, magnetic resonance imaging, and electrophysiology for predicting neurodevelopmental outcomes of neonates with hypoxic-ischemic encephalopathy: a prospective study.BMC Pediatr. 2022 May 17;22(1):290. doi: 10.1186/s12887-022-03329-8. BMC Pediatr. 2022. PMID: 35581579 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources